Intrapartum Rapid GBS Testing in Patients Presenting With Threatened Preterm Labor
NCT02511444
Group B Streptococcus
Long Beach, California, United States
View Trial DetailsNCT Number: NCT01251289
A retrospective review of the prevalence of Group B Streptococcus Positive Pregnant Patients in an Inner City Tertiary Care Center
Looking for future studies?
Notify MeThis is a retrospective chart review of the prevalence of Group B Streptococcus (GBS) positive patients
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Unity Health Toronto
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02511444
Group B Streptococcus
Long Beach, California, United States
View Trial DetailsNCT01982084
Behavior, Group B Streptococcus
Edinburgh, United Kingdom
View Trial DetailsNCT01150123
Autoimmune Diseases, Autoimmune Diseases of the Nervous System
Ghent, Belgium
View Trial DetailsNCT01180023
Group B Streptococcus
Washington D.C., District of Columbia, United States
View Trial Details